
AEON Biopharma’s Exciting Journey to the Leerink Global Healthcare Conference: A Peek into Their Innovative World!
AEON Biopharma’s CEO, Marc Forth, to Present at Leerink Global Healthcare Conference IRVINE, Calif., March 4, 2025. AEON Biopharma, a pioneering clinical-stage biopharmaceutical company, is making waves in the healthcare industry with its focus on developing a botulinum toxin complex under the 351(k) biosimilar pathway. The Company’s dynamic leadership, AEON’s President and CEO, Marc Forth,…